Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C10H12FNO2 |
| Molecular Weight | 197.2062 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NCC(CC(O)=O)C1=CC=C(F)C=C1
InChI
InChIKey=QWHXHLDNSXLAPX-UHFFFAOYSA-N
InChI=1S/C10H12FNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)
| Molecular Formula | C10H12FNO2 |
| Molecular Weight | 197.2062 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:40:30 GMT 2025
by
admin
on
Wed Apr 02 08:40:30 GMT 2025
|
| Record UNII |
6DAU7M5P3D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-4-Fluorophenibut
Created by
admin on Wed Apr 02 08:40:30 GMT 2025 , Edited by admin on Wed Apr 02 08:40:30 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6DAU7M5P3D
Created by
admin on Wed Apr 02 08:40:30 GMT 2025 , Edited by admin on Wed Apr 02 08:40:30 GMT 2025
|
PRIMARY | |||
|
DTXSID00966612
Created by
admin on Wed Apr 02 08:40:30 GMT 2025 , Edited by admin on Wed Apr 02 08:40:30 GMT 2025
|
PRIMARY | |||
|
103611
Created by
admin on Wed Apr 02 08:40:30 GMT 2025 , Edited by admin on Wed Apr 02 08:40:30 GMT 2025
|
PRIMARY | |||
|
52237-19-1
Created by
admin on Wed Apr 02 08:40:30 GMT 2025 , Edited by admin on Wed Apr 02 08:40:30 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
It is less potent as a GABAB receptor agonist than baclofen but more potent than phenibut.
|
||
|
TARGET -> AGONIST |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
